Annual Shareholders Equity
$131.98 M
+$85.47 M+183.81%
30 June 2024
Summary:
Renovaro Biosciences annual stockholders equity is currently $131.98 million, with the most recent change of +$85.47 million (+183.81%) on 30 June 2024. During the last 3 years, it has fallen by -$42.69 million (-24.44%). RENB annual shareholders equity is now -24.44% below its all-time high of $174.66 million, reached on 01 June 2021.RENB Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$98.09 M
-$33.89 M-25.68%
30 September 2024
Summary:
Renovaro Biosciences quarterly stockholders equity is currently $98.09 million, with the most recent change of -$33.89 million (-25.68%) on 30 September 2024. Over the past year, it has increased by +$54.49 million (+124.99%). RENB quarterly shareholders equity is now -43.84% below its all-time high of $174.66 million, reached on 01 June 2021.RENB Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RENB Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +183.8% | +125.0% |
| 3 y3 years | -24.4% | -40.8% |
| 5 y5 years | -23.8% | -42.7% |
RENB Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -24.4% | +183.8% | -41.8% | +125.0% |
| 5 y | 5 years | -24.4% | +183.8% | -43.8% | +125.0% |
| alltime | all time | -24.4% | >+9999.0% | -43.8% | +3828.4% |
Renovaro Biosciences Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $98.09 M(-25.7%) |
| June 2024 | $131.98 M(+183.8%) | $131.98 M(-21.7%) |
| Mar 2024 | - | $168.60 M(+286.7%) |
| Dec 2023 | - | $43.60 M(-6.7%) |
| Sept 2023 | - | $46.75 M(+0.5%) |
| June 2023 | $46.50 M(-36.0%) | - |
| June 2023 | - | $46.50 M(-29.7%) |
| Mar 2023 | - | $66.13 M(-1.2%) |
| Dec 2022 | - | $66.90 M(-4.9%) |
| Sept 2022 | - | $70.32 M(-3.2%) |
| June 2022 | $72.62 M(-58.4%) | $72.62 M(-55.0%) |
| Mar 2022 | - | $161.24 M(-2.6%) |
| Dec 2021 | - | $165.62 M(-0.8%) |
| Sept 2021 | - | $166.97 M(-4.4%) |
| June 2021 | $174.66 M(+5.0%) | $174.66 M(+7.6%) |
| Mar 2021 | - | $162.32 M(+0.2%) |
| Dec 2020 | - | $161.94 M(-1.4%) |
| Sept 2020 | - | $164.23 M(-1.2%) |
| June 2020 | $166.27 M(-3.9%) | $166.27 M(-2.3%) |
| Mar 2020 | - | $170.22 M(-0.6%) |
| Dec 2019 | - | $171.28 M(-0.5%) |
| Sept 2019 | - | $172.18 M(-0.5%) |
| June 2019 | $173.10 M(+9.0%) | $173.10 M(+20.2%) |
| Mar 2019 | - | $143.97 M(-3.2%) |
| Dec 2018 | - | $148.72 M(-3.2%) |
| Sept 2018 | - | $153.59 M(-3.2%) |
| June 2018 | $158.74 M | $158.74 M(+10.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $143.36 M(+7637.8%) |
| Dec 2017 | - | $1.85 M(-32.9%) |
| Sept 2017 | - | $2.76 M(+80.1%) |
| June 2017 | $1.53 M(-340.5%) | $1.53 M(-195.4%) |
| Mar 2017 | - | -$1.61 M(+25.1%) |
| Dec 2016 | - | -$1.28 M(+60.9%) |
| Sept 2016 | - | -$798.00 K(+25.2%) |
| June 2016 | -$637.40 K(-159.2%) | -$637.40 K(+905.4%) |
| Mar 2016 | - | -$63.40 K(-114.4%) |
| Dec 2015 | - | $441.80 K(-38.4%) |
| Sept 2015 | - | $717.00 K(-73.2%) |
| June 2015 | $1.08 M(-69.1%) | - |
| Mar 2015 | - | $2.67 M(-23.3%) |
| Dec 2014 | $3.48 M(-6887.9%) | $3.48 M(-246.2%) |
| Sept 2014 | - | -$2.38 M(-9.5%) |
| June 2014 | - | -$2.63 M(+20.3%) |
| Mar 2014 | - | -$2.19 M(+2660.2%) |
| Dec 2013 | - | -$79.20 K(+12.2%) |
| Sept 2013 | - | -$70.60 K(+30.3%) |
| June 2013 | - | -$54.20 K(+5.7%) |
| Mar 2013 | -$51.30 K(+274.5%) | -$51.30 K(+23.3%) |
| Dec 2012 | - | -$41.60 K(+31.2%) |
| Sept 2012 | - | -$31.70 K(+28.3%) |
| June 2012 | - | -$24.70 K(+80.3%) |
| Mar 2012 | -$13.70 K(+57.5%) | -$13.70 K(+47.3%) |
| Dec 2011 | - | -$9300.00 |
| Mar 2011 | -$8700.00 | - |
FAQ
- What is Renovaro Biosciences annual stockholders equity?
- What is the all time high annual shareholders equity for Renovaro Biosciences?
- What is Renovaro Biosciences annual shareholders equity year-on-year change?
- What is Renovaro Biosciences quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Renovaro Biosciences?
- What is Renovaro Biosciences quarterly shareholders equity year-on-year change?
What is Renovaro Biosciences annual stockholders equity?
The current annual shareholders equity of RENB is $131.98 M
What is the all time high annual shareholders equity for Renovaro Biosciences?
Renovaro Biosciences all-time high annual stockholders equity is $174.66 M
What is Renovaro Biosciences annual shareholders equity year-on-year change?
Over the past year, RENB annual stockholders equity has changed by +$85.47 M (+183.81%)
What is Renovaro Biosciences quarterly stockholders equity?
The current quarterly shareholders equity of RENB is $98.09 M
What is the all time high quarterly shareholders equity for Renovaro Biosciences?
Renovaro Biosciences all-time high quarterly stockholders equity is $174.66 M
What is Renovaro Biosciences quarterly shareholders equity year-on-year change?
Over the past year, RENB quarterly stockholders equity has changed by +$54.49 M (+124.99%)